- Spiral has been recognized for its innovative Drug Delivery Platform in the fourth annual Hearing Technology Innovator Awards™
SOUTH SAN FRANCISCO, Calif., August 30, 2023 — Spiral Therapeutics, Inc. (“Spiral”), a clinical-stage company focused on delivering therapies for inner ear disorders, today announced today that it has been recognized for its innovative Drug Delivery Platform in the fourth annual Hearing Technology Innovator Awards™.
The annual awards program by Hearing Health & Technology Matters (HHTM) acknowledges technological innovation and accomplishments in the hearing industry. This year’s program featured numerous innovative technologies submitted by companies from all around the world across eight distinct categories.
Since 2020, the awards program has raised over $25,000 in support of hearing-related charities. This year, the proceeds have benefited organizations such as the Hearing Health Foundation, SoundWrx, and the Hearing Loss Association of America.
“The Innovator Awards aim to acknowledge the individuals and organizations that transform groundbreaking hearing care concepts into reality,” explained Dr. Robert Traynor, member of the 2023 Awards program judge’s panel. “Companies like Spiral Therapeutics are playing a pivotal role in advancing innovation throughout the industry.”
About the Hearing Technology Innovator Awards
The Hearing Technology Innovator Awards™ is an international awards program designed to recognize and celebrate innovation within the hearing industry. Since its inception, the program has helped raise over $25,000 for hearing charities. Learn more at https://hearinghealthmatters.org/hearing-technology-innovator-awards/
About HHTM
Hearing Health & Technology Matters (HHTM) provides timely information and lively insights to anyone who cares about hearing loss. Readers and contributors are drawn from many sectors of the hearing field, including practitioners, researchers, manufacturers, educators, and, importantly, consumers with hearing loss and those who love them. By involving all these groups, we hope to bridge the gaps in knowledge that so often divide them. To learn more, visit HearingHealthMatters.org.
About Spiral Therapeutics
Spiral Therapeutics is a clinical-stage company focused on delivering therapies for inner ear disorders. Spiral’s novel drug delivery platform allows for minimally invasive, precise and durable exposure of drugs to the cochlea. Spiral is advancing a therapeutic pipeline with focus on hearing loss and balance disorders. Spiral’s lead program, SPT-2101, is a sustained-release steroid formulation for the treatment of inner ear inflammation. For more information, visit: www.spiraltx.com.